Delivery Order SPE2DB22D3016-SPE2DB24FAPR1
Award Date
3/8/24
Potential Completion Date
3/11/24
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pen. The contract, valued at $48,857.86, is a delivery order with a firm fixed price structure and an ultimate completion date of September 6, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ05M, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $22,112.30 and is for the delivery of pharmaceutical products, including the medication Dupixent 300 mg/2 ml pen. The contract has a firm fixed price pricing type and an ultimate completion date of December 1, 2023. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $11,267.53, is for the delivery of Dupixent 300 mg/2 ml pens. This is a firm fixed-price delivery order contract with an ultimate completion date of January 29, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $8,456.60, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a completion date of February...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Dupixent 300 mg/2 ml pens. The award, valued at $23,915.18, is a firm fixed-price delivery order contract with a completion date of February 28, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $10,721.75, is a delivery order for the pharmaceutical product Dupixent 300 mg/2 ml pen with an ultimate completion date of January 26, 2024. The contract is a firm fixed-price arrangement, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
This federal contract award, valued at $11,248.65, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of November 7, 2023. The contract has a firm fixed price pricing type and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, with ID SPE2DX15D2101|SPE2DX24F49WV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Dupixent 300 mg/2 ml pen in 2 ml quantities, a pharmaceutical product used for various medical treatments. The contract has a ceiling value of $13,388.79 and a completion date of February 9, 2024. It is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The $5,083.16 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., that supports the DLA Troop Support Medical in providing pharmaceutical products and medical supplies to military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The $7,024.36 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (Amerisourcebergen's parent company) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a...